In patients with high-risk tumors, those treated with segmental ureterectomy did not have worse overall survival compared with those who underwent radical nephroureterectomy. Segmental ureterectomy ...
PRINCETON, N.J.,--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, ...
The patency rate at 6 months was higher for the silicone-coated metallic stent vs double-J stent. A silicone-covered metallic stent maintains patency better than a double-J stent in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results